Clinical studies show patients can lose up to 25% of their total body weight in just a matter of months with Tirzepatide
Currently, there is not enough data, evidence, or clinical studies [to say] who might be at higher risk for headaches with Zepbound or other GLP-1 meds, Dr
Its also not recommended for those who are pregnant or breastfeeding or who have a history of pancreatitis
Front Cell Infect Microbiol 2021;11:595575.ArticlePubMedPMC 97
Those with known glutathione allergy or sulfite sensitivity: Though rare, if youve had a bad reaction to glutathione in the past (or to N-acetylcysteine, a related compound), you should not risk an IV push
The risk of kidney damage with tirzepatide and alcohol is an important consideration